(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 128.69%199.67M | 52.29%159.06M | -20.75%97.81M | -20.75%97.81M | -41.73%83.46M | -50.93%87.31M | -51.81%104.45M | -48.55%123.43M | -48.55%123.43M | -40.83%143.23M |
-Cash and cash equivalents | 132.14%198.63M | 54.17%157.66M | -20.17%96.48M | -20.17%96.48M | -42.26%82.01M | -51.30%85.56M | -51.93%102.27M | -48.95%120.86M | -48.95%120.86M | -40.60%142.05M |
-Accounts receivable | 595.31%34.36M | -16.99%13.3M | -3.18%11.04M | -3.18%11.04M | 41.65%13.72M | 30.88%4.94M | 136.99%16.02M | 94.59%11.4M | 94.59%11.4M | -12.13%9.69M |
-Other receivables | --15.18M | --18.63M | --14.38M | --14.38M | ---- | ---- | ---- | ---- | ---- | ---- |
Total current assets | 79.11%380.09M | 36.26%322.49M | 3.56%249.46M | 3.56%249.46M | -7.32%234.96M | -23.26%212.21M | -19.52%236.68M | -28.57%240.87M | -28.57%240.87M | -24.02%253.51M |
Non current assets | ||||||||||
-Accumulated depreciation | ---- | ---- | -7.31%-747.25M | -7.31%-747.25M | ---- | ---- | ---- | -6.48%-696.37M | -6.48%-696.37M | ---- |
-Long term equity investment | 14.82%725.27M | -2.30%622.98M | 7.41%610.23M | 7.41%610.23M | 21.43%668.82M | 21.77%631.68M | 26.27%637.67M | 10.37%568.16M | 10.37%568.16M | 5.77%550.79M |
-Including:Held to maturity investments | --0 | 2.37%3.25M | -42.22%3.72M | -42.22%3.72M | -90.92%2.64M | -74.54%7.63M | 361.98%3.17M | 65.09%6.45M | 65.09%6.45M | 94.50%29.05M |
Non current note receivables | ---- | ---- | ---- | ---- | --9.92M | --11.91M | ---- | ---- | ---- | ---- |
-Goodwill | 3.26%5.64M | 0.14%5.58M | -2.18%5.46M | -2.18%5.46M | -0.94%5.6M | 2.80%5.46M | 8.19%5.57M | 6.83%5.58M | 6.83%5.58M | 7.60%5.65M |
Regulatory assets | 595.31%34.36M | -16.99%13.3M | 24.89%16.51M | 24.89%16.51M | 41.65%13.72M | 30.88%4.94M | 136.99%16.02M | 37.68%13.22M | 37.68%13.22M | -12.13%9.69M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Current debt and capital lease obligation | -26.25%28.52M | -25.55%30.36M | 50.24%27.66M | 50.24%27.66M | 193.21%38.61M | 171.87%38.67M | 147.08%40.77M | 0.57%18.41M | 0.57%18.41M | -31.89%13.17M |
-Current debt | -47.24%13.65M | -46.15%13.27M | 30.82%11.11M | 30.82%11.11M | 392.96%26.39M | 384.55%25.88M | 317.90%24.64M | 29.82%8.49M | 29.82%8.49M | -25.16%5.35M |
-Bank in debtedness | --6.02M | --5.77M | --5.51M | --5.51M | ---- | ---- | ---- | --0 | --0 | ---- |
-Current capital lease obligation | -30.86%8.85M | -29.85%11.32M | 11.29%11.04M | 11.29%11.04M | 56.35%12.22M | 44.01%12.79M | 52.14%16.14M | -15.69%9.92M | -15.69%9.92M | -35.85%7.81M |
-accounts payable | 43.80%110.3M | 25.39%96.6M | -9.97%28.56M | -9.97%28.56M | -14.83%71.71M | -1.09%76.7M | 12.69%77.04M | 5.38%31.72M | 5.38%31.72M | 51.68%84.19M |
-Total tax payable | 46.07%1.33B | 34.73%1.21B | 22.40%991.03M | 22.40%991.03M | 26.12%960.23M | 25.75%913.17M | 25.55%896.13M | 12.26%809.64M | 12.26%809.64M | 7.15%761.35M |
-Other payable | 48.30%35.63M | 130.98%31.65M | 1,255.51%24.25M | 1,255.51%24.25M | 1,157.51%22.7M | 1,294.31%24.02M | 713.78%13.7M | 5.11%1.79M | 5.11%1.79M | -52.66%1.81M |
Current accrued expenses | -24.49%10.5M | -0.36%4.71M | 15.99%57.09M | 15.99%57.09M | -0.92%4.75M | 2.80%13.91M | 8.16%4.73M | 26.62%49.22M | 26.62%49.22M | 7.58%4.8M |
Current deferred liabilities | -16.77%10.4M | -28.39%9.05M | -14.25%10.35M | -14.25%10.35M | -11.74%7.11M | 54.28%12.5M | 151.55%12.64M | -10.24%12.07M | -10.24%12.07M | 3.17%8.05M |
Current liabilities | 27.97%182.05M | 20.59%163.42M | 25.35%141.19M | 25.35%141.19M | 11.80%124.34M | 24.10%142.26M | 41.10%135.52M | 8.85%112.64M | 8.85%112.64M | 25.02%111.21M |
Non current liabilities | ||||||||||
-Long term debt | -44.90%5.92M | -41.20%6.48M | -33.48%6.93M | -33.48%6.93M | -0.16%8.5M | 24.28%10.74M | 13.43%11.02M | -8.49%10.42M | -8.49%10.42M | -39.06%8.51M |
Non current accrued expenses | 33.54%1.55B | 29.97%1.48B | 24.95%1.29B | 24.95%1.29B | 22.17%1.19B | 26.58%1.16B | 30.52%1.13B | 22.84%1.03B | 22.84%1.03B | 21.05%970.14M |
Due to related parties non current | --72.49M | --69.65M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Derivative product liabilities | --31.1M | --16.04M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Long term provisions | 15.85%719.35M | -1.62%616.5M | 8.17%603.3M | 8.17%603.3M | 21.77%660.32M | 21.73%620.94M | 26.52%626.65M | 10.79%557.74M | 10.79%557.74M | 7.01%542.27M |
Employee benefits | ---- | ---- | ---- | ---- | 26.45%3.91M | 58.31%4.37M | -8.60%5.15M | ---- | ---- | -44.02%3.09M |
Total non current liabilities | 43.63%1.52B | 32.88%1.37B | 22.76%1.13B | 22.76%1.13B | 24.30%1.08B | 25.52%1.06B | 27.39%1.03B | 11.83%922.28M | 11.83%922.28M | 9.14%872.56M |
Shareholders'equity | ||||||||||
Share capital | 1.34%490.95M | 0.62%487.2M | 1.29%486.14M | 1.29%486.14M | 1.02%484.6M | 0.99%484.48M | 0.95%484.21M | 0.70%479.93M | 0.70%479.93M | 1.02%479.73M |
-common stock | 1.34%490.95M | 0.62%487.2M | 1.29%486.14M | 1.29%486.14M | 1.02%484.6M | 0.99%484.48M | 0.95%484.21M | 0.70%479.93M | 0.70%479.93M | 1.02%479.73M |
Additional paid-in capital | 4.67%55.65M | 6.92%55.75M | -1.72%54.83M | -1.72%54.83M | -1.12%54.24M | -1.61%53.17M | -2.09%52.14M | 0.71%55.8M | 0.71%55.8M | -0.94%54.86M |
Gains losses not affecting retained earnings | 70.84%30.3M | 3.61%26.67M | -38.20%16.56M | -38.20%16.56M | -6.89%27M | 71.42%17.74M | 546.08%25.74M | 302.95%26.79M | 302.95%26.79M | 288.36%29M |
Total equity | 39.34%1.98B | 31.89%1.84B | 22.50%1.57B | 22.50%1.57B | 18.45%1.46B | 17.81%1.42B | 18.81%1.39B | 8.07%1.28B | 8.07%1.28B | 7.59%1.23B |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.